Neptune Technologies & Bioresources Inc Debt to Equity Ratio 2009-2018 | NEPT

Current and historical debt to equity ratio values for Neptune Technologies & Bioresources Inc (NEPT) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Neptune Technologies & Bioresources Inc debt/equity for the three months ending December 31, 2018 was 0.00.
Neptune Technologies & Bioresources Inc Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-12-31 $0.00B $0.06B 0.00
2018-09-30 $0.00B $0.07B 0.00
2018-06-30 $0.00B $0.06B 0.00
2016-11-30 $0.01B $0.05B 0.25
2016-08-31 $0.02B $0.05B 0.33
2016-05-31 $0.02B $0.05B 0.35
2016-03-31 $0.02B $0.05B 0.34
2016-02-29 $0.00B $0.00B 0.00
2015-12-31 $0.01B $0.05B 0.18
2015-09-30 $0.01B $0.05B 0.19
2015-06-30 $0.01B $0.06B 0.19
2015-03-31 $0.01B $0.07B 0.19
2014-12-31 $0.01B $0.07B 0.17
2014-09-30 $0.01B $0.08B 0.18
2014-06-30 $0.01B $0.09B 0.11
2014-03-31 $0.01B $0.06B 0.16
2013-12-31 $0.00B $0.05B 0.04
2013-09-30 $0.00B $0.05B 0.04
2013-06-30 $0.00B $0.05B 0.04
2013-03-31 $0.00B $0.06B 0.03
2013-02-28 $0.00B $0.00B 0.00
2012-12-31 $0.00B $0.06B 0.07
2012-09-30 $0.00B $0.03B 0.13
2012-06-30 $0.00B $0.03B 0.13
2012-03-31 $0.00B $0.03B 0.09
2011-12-31 $0.00B $0.03B 0.10
2011-09-30 $0.00B $0.03B 0.13
2011-06-30 $0.00B $0.02B 0.15
2011-03-31 $0.00B $0.01B 0.27
2010-12-31 $0.00B $0.02B 0.26
2010-09-30 $0.01B $0.01B 0.45
2010-06-30 $0.01B $0.01B 0.51
2010-03-31 $0.01B $0.01B 0.66
2009-12-31 $0.01B $0.01B 0.69
2009-09-30 $0.01B $0.01B 1.30
2009-06-30 $0.01B $0.01B 0.75
2009-03-31 $0.01B $0.01B 0.56
2008-12-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.238B $0.022B
Neptune Wellness Solutions Inc. operates as a nutrition supplement company. It develops and produces cannabis products, marine oils, seed oils and pet supplements. Neptune Wellness Solutions Inc., formerly known as Neptune Technologies & Bioressources Inc., is headquartered in Laval, Canada.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $136.952B 27.07
Medtronic (MDT) Ireland $121.227B 17.72
Stryker (SYK) United States $72.547B 26.60
Boston Scientific (BSX) United States $51.696B 25.20
Baxter (BAX) United States $39.588B 25.33
Zimmer Biomet Holdings (ZBH) United States $25.898B 16.58
Smith & Nephew SNATS (SNN) United Kingdom $17.446B 0.00
Canopy Growth (CGC) Canada $14.852B 0.00
ResMed (RMD) United States $14.350B 27.21
Bio-Rad Laboratories (BIO) United States $9.156B 52.24
Aurora Cannabis (ACB) Canada $9.141B 64.50
Hill-Rom Holdings (HRC) United States $6.962B 21.53
Perrigo (PRGO) Ireland $6.420B 10.41
Insulet (PODD) United States $5.800B 1956.80
GW Pharmaceuticals (GWPH) United Kingdom $5.092B 0.00
ICU Medical (ICUI) United States $4.698B 29.24
Haemonetics (HAE) United States $4.311B 38.24
Hutchison China MediTech (HCM) China $3.810B 0.00
Agios Pharmaceuticals (AGIO) United States $3.637B 0.00
Neogen (NEOG) United States $3.108B 47.74
NuVasive (NUVA) United States $2.892B 25.23
Quidel (QDEL) United States $2.514B 22.68
Aphria (APHA) $2.385B 105.89
National Vision Holdings (EYE) United States $2.274B 44.72
Cardiovascular Systems (CSII) United States $1.346B 966.50
Phibro Animal Health (PAHC) United States $1.283B 18.45
VAREX IMAGING (VREX) United States $1.275B 24.96
AtriCure (ATRC) United States $1.081B 0.00
MacroGenics (MGNX) United States $0.926B 0.00
Lantheus Holdings (LNTH) United States $0.911B 24.60
Cerus (CERS) United States $0.844B 0.00
PetIQ (PETQ) United States $0.831B 23.77
Omeros (OMER) United States $0.828B 0.00
NanoString Technologies (NSTG) United States $0.729B 0.00
Meridian Bioscience (VIVO) United States $0.715B 21.30
OraSure Technologies (OSUR) United States $0.664B 29.11
Eagle Pharmaceuticals (EGRX) United States $0.657B 22.35
Evolus (EOLS) United States $0.655B 0.00
TG Therapeutics (TGTX) United States $0.601B 0.00
LeMaitre Vascular (LMAT) United States $0.596B 28.35
Surmodics (SRDX) United States $0.563B 81.90
Quanterix (QTRX) United States $0.518B 0.00
BioLife Solutions (BLFS) United States $0.364B 150.23
Vapotherm (VAPO) United States $0.335B 0.00
Rockwell Medical (RMTI) United States $0.331B 0.00
Insys Therapeutics (INSY) United States $0.328B 0.00
Utah Medical Products (UTMD) United States $0.300B 19.49
Owens & Minor (OMI) United States $0.271B 3.76
Bovie Medical (APYX) United States $0.260B 0.00
Cytosorbents (CTSO) United States $0.241B 0.00
Zynex (ZYXI) United States $0.145B 15.52
Fonar (FONR) United States $0.137B 7.33
Surface Oncology (SURF) United States $0.116B 0.00
Chimerix (CMRX) United States $0.102B 0.00
Female Health (VERU) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.096B 0.00
United-Guardian (UG) United States $0.087B 19.84
CAS Medical Systems (CASM) United States $0.072B 0.00
Neurotrope (NTRP) United States $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.058B 17.14
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Valeritas Holdings (VLRX) United States $0.035B 0.00
Senestech (SNES) United States $0.029B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.008B 15.29